KOSPI · Healthcare · ₩147B
₩8,190-0.24%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 1.9% · as of 26.10.27
Among 98 제약 peers
Quarterly Revenue Growth
“이번 분기, 주력 제품 강점에 이익 개선까지 더해졌어요.”
In the company's words · 2026 2분기 filing